THIELE, H., E. M. OHMAN, S. DEWAHA-THIELE, U. ZEYMER and S. DESCH. Management of cardiogenic shock complicating myocardial infarction: an update 2019. European heart journal. Oxford: Oxford University Press, 2019, vol. 40, No 32, p. "2671"-"+", 15 pp. ISSN 0195-668X. Available from: https://dx.doi.org/10.1093/eurheartj/ehz363.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Management of cardiogenic shock complicating myocardial infarction: an update 2019
Authors THIELE, H., E. M. OHMAN, S. DEWAHA-THIELE, U. ZEYMER and S. DESCH.
Edition European heart journal, Oxford, Oxford University Press, 2019, 0195-668X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30230 Other clinical medicine subjects
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW DAPT-SHOCK AMI
Impact factor Impact factor: 22.673
RIV identification code RIV/00216224:14110/19:00123181
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1093/eurheartj/ehz363
UT WoS 000490152600009
Keywords (in Czech) DAPT-SHOCK AMI; Shock; Heart failure; Treatment; Percutaneous coronary intervention; Myocardial infarction; Assist device
Keywords in English DAPT-SHOCK AMI; Shock; Heart failure; Treatment; Percutaneous coronary intervention; Myocardial infarction; Assist device
Tags Excelence Science, MU, RIV, UK LF PRAHA, user
Tags International impact, Reviewed
Changed by Changed by: Bc. Hana Vladíková, BBA, učo 244692. Changed: 10/2/2022 13:49.
Abstract
Dual Antiplatelet Therapy for Shock patients with Acute Myocardial Infarction (DAPT-SHOCK-AMI) trial (ClinicalTrials.gov: NCT03551964). Cardiogenic shock (CS) remains the most common cause of death in patients admitted with acute myocardial infarction (AMI) and mortality remained nearly unchanged in the range of 40-50% during the last two decades. Early revascularization, vasopressors and inotropes, fluids, mechanical circulatory support, and general intensive care measures are widely used for CS management. However, there is only limited evidence for any of the above treatment strategies except for revascularization and the relative ineffectiveness of intra-aortic balloon pumping. This updated review will outline the management of CS complicating AMI with major focus on state-of-the art treatment.
Links
90090, large research infrastructuresName: CZECRIN II
PrintDisplayed: 17/7/2024 21:26